/ciol/media/agency_attachments/c0E28gS06GM3VmrXNw5G.png)
Follow UsBANGALORE, INDIA: Symphony Service Corp., a provider in software product engineering outsourcing services today announced Symphony Services SymTEMS, its multi-patented, end-to-end test automation framework that reduces client Q/A costs by up to 50 per cent while achieving a nearly 40 per cent faster time-to-market for new products.
SymTEMS marks the first in a series of solutions that Symphony would announce over the next several months that will underscore the company’s commitment to engineering outcome certainty in bolstering the performance of clients’ software product R&D organizations, said a press release.
While many CTOs are eager to capitalize on automated testing – which frees the in-house product R&D team to focus on strategic product design and development – industry analysts peg adoption of automated Q/A at only 10 percent.
Most product R&D organizations are simply unable to align their Q/A with business goals, and lack the automated Q/A expertise needed to capitalize on the performance and cost savings of automation.
As a result they experience inadequate test coverage while spending upwards of 50 percent of their R&D budgets on Q/A.
Symphony Services has further distanced itself from competitors in the outsourced software product engineering space by securing two crucial patents for its test automation framework.
The company’s U.S. Patent Nos. 10/756,894 and 10/757,718 increase the maintainability of test scripts and reduce the overall maintenance costs associated with automation, said the release.
“Even though most companies are ill-equipped to run automated Q/A internally, software product vendors and software-enabled companies across all vertical markets recognize the huge cost-savings associated with it,” said Sunil Gupta, vice president, product quality, Symphony Services.
He further added that they would continue to lead the market with innovative, automated Q/A services our client’s can take advantage of that ensure they realize maximum return on their testing dollar.